Checkmate8HW

First-line immunotherapy combination improves outcomes in patients with metastatic colorectal cancer versus chemotherapy

Led by Thierry Andre, Head of the Department of Medical Oncology at the Hôpital Saint Antoine in Paris, the phase…

First results of the Checkmate 8HW study show first-line dual immunotherapy combination improves outcomes versus standard chemotherapy in metastatic colorectal cancer subtype

Checkmate 8HW is the first phase III study to assess first-line nivolumab plus ipilimumab in patients with unresectable microsatellite instability-high/mismatch…